ORYZF   $2.45  -11.55% Market Closed

ORYZON GENOMICS SA
Total Cash
totalCashPerShare
EBITDA 91.85K
Total Debt
quickRatio
currentRatio
Total Revenue 15.83M
debtToEquity
Revenue/Share 0.25
ROA
ROE
grossProfits
freeCashflow
operatingCashflow
earningsGrowth
revenueGrowth
grossMargins 0.98283
ebitdaMargins 0.0058
operatingMargins -0.0028900001
profitMargins -0.28781998
enterpriseValue
forwardPE
floatShares 53.51M
sharesOutstanding 63.59M
sharesShort
sharesShortPriorMonth
dateShortInterest
sharesPercentSharesOut
heldPercentInsiders 0.17%
heldPercentInstitutions 0.01%
Short Ratio help_outline
shortPercentOfFloat
impliedSharesOutstanding
bookValue 1.343
Price To Book help_outline 1.44
earningsQuarterlyGrowth
netIncomeToCommon -4.56M
trailingEps -0.07%
forwardEps
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 8
lastUpdated Nov. 7, 2024, 3:09 a.m.